Skip to content
Posted on January 30, 2023 by: remi

Toyota: Sales, Production, and Export Results for 2022 (January – December)

Southeast Asia Chronicle
Posted on January 30, 2023 by: remi

Toyota: Sales, Production, and Export Results for 2022 (January – December)

  • Home
  • SEAPRWire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact

Tag: drug

  • Home
  • drug
Posted on January 12, 2023 by: tove

Novotech Acquires US-based Drug Development Consulting Firm, CBR International

SINGAPORE, Jan 12, 2023 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a …

Continue Reading
Posted on December 15, 2022 by: tove

Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding

FREMONT, CA, Dec 14, 2022 – (ACN Newswire via SEAPRWire.com) – Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published …

Continue Reading
Posted on December 6, 2022 by: tove

Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials

SYDNEY, AU, Dec 6, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & …

Continue Reading
Posted on November 15, 2022 by: eqs

巨生医MPB-1734抗癌药物新剂型取得成分专利

EQS 新闻 via SEAPRWire.com / 2022-11-15 / 10:41 UTC+8 【巨生生医(6827)巨生医MPB-1734取得成分专利新闻稿】 发布日期:2022年11月15日 巨生医MPB-1734抗癌药物新剂型…

Continue Reading
Posted on November 2, 2022 by: remi

Eisai Announces Plans to Submit Application for Partial Change to Label for Dosage and Administration of Aricept for Treatment of Dementia with Lewy Bodies Based on Results of Drug Reexamination

TOKYO, Nov 2, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has received notification that Aricept (donepezil hydrochloride), a …

Continue Reading
Posted on October 10, 2022 by: tove

Hua Medicine’s Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China

SHANGHAI, CHINA, Oct 10, 2022 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, HKEx Stock Code: 2552.HK) today announces that the New Drug …

Continue Reading
Posted on July 26, 2022 by: tove

Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer

Foster City, CA, and Hangzhou, China, Jul 26, 2022 – (ACN Newswire via SEAPRWire.com) – Apollomics Inc. an innovative biopharmaceutical company committed to the discovery …

Continue Reading
Posted on May 17, 2022 by: remi

Fujitsu and RIKEN start joint research on next-generation IT drug discovery technology using the supercomputer Fugaku and simulation integrated AI

TOKYO, May 17, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu Limited and RIKEN today launched a joint research project on next-generation IT drug discovery …

Continue Reading
Posted on May 10, 2022 by: remi

Eisai Initiates Preparation for New Drug Application, Based on the Results of an Investigator-Initiated Clinical Trial of Ultrahigh-Dose Mecobalamin for Amyotrophic Lateral Sclerosis in Japan

TOKYO, May 10, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. today announced that it has initiated preparation on a New Drug Application …

Continue Reading
Posted on March 7, 2022 by: remi

Fujitsu and Tokyo Medical and Dental University leverage world’s fastest supercomputer and AI technology for scientific discovery to shed light on drug resistance in cancer treatment

TOKYO, Mar 7, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu and the Tokyo Medical and Dental University (TMDU) today announced a new technology that …

Continue Reading
Posted on February 23, 2022 by: tove

Lepu Biopharma Co., Ltd. Successfully Listed on the Main Board of HKEX

HONG KONG, Feb 23, 2022 – (ACN Newswire via SEAPRWire.com) – The biopharmaceutical company focusing on oncology therapeutics – Lepu Biopharma Co., Ltd. (“Lepu Biopharma” …

Continue Reading
Posted on August 13, 2021 by: tove

TOT BIOPHARM 2021 Interim Revenue Surges 78% to RMB23.13 million

HONG KONG, Aug 13, 2021 – (ACN Newswire via SEAPRWire.com) – TOT BIOPHARM International Company Limited (“TOT BIOPHARM” or the “Group”; stock code: 1875.HK), a …

Continue Reading
Posted on May 24, 2021 by: tove

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration

HONG KONG, May 24, 2021 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”; stock code: 6622), an ophthalmic pharmaceutical …

Continue Reading
Posted on April 23, 2021 by: tove

Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China – First Glucokinase Activator (GKA) Globally

SHANGHAI, CHINA, Apr 23, 2021 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, Stock Code: 2552.HK), today announced that the New Drug Application …

Continue Reading
Posted on April 22, 2021 by: ada

Prices of scarce Covid-19 drugs soar on India’s black market

BANGALORE – India faces a grave shortage of at least three drugs essential for treating Covid-19 patients, as the country sees infections surge to over …

Continue Reading
Posted on April 7, 2021 by: remi

Hitachi and Axcelead have agreed to start joint development of solutions contributing on more efficient creation of next-generation biopharmaceuticals

TOKYO, Apr 7, 2021 – (JCN Newswire via SEAPRWire.com) – Hitachi, Ltd. (TSE:6501) and Axcelead, Inc. today announced that they have agreed on a comprehensive …

Continue Reading
Posted on November 30, 2020 by: remi

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies

TOKYO, Nov 30, 2020 – (JCN Newswire) – Eisai Co., Ltd. and Wren Therapeutics Ltd. today announced that the companies have entered into an exclusive …

Continue Reading
Posted on November 13, 2020 by: remi

Fujitsu: Establishment of Joint Venture Aimed at the Development of Therapeutics for the Treatment of Coronavirus Disease

TOKYO, Nov 13, 2020 – (JCN Newswire) – PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (TSE:4587), Fujitsu Limited (TSE:6702), Mizuho Capital Co., Ltd. which is …

Continue Reading
Posted on October 14, 2020 by: tove

Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin

SHANGHAI, CHINA, Oct 14, 2020 – (ACN Newswire) – Hua Medicine (the “Company”, Stock Code: 2552.HK) announces that, after review and on-site verification under the …

Continue Reading

Categories

  • ACN Newswire
  • EQS Newswire
  • JCN Newswire
  • SEAPRWire

Latest News

  • Toyota: Sales, Production, and Export Results for 2022 (January – December) January 30, 2023
  • Lecanemab Receives Priority Review Status in Japan January 30, 2023
  • Two Hitachi Group Companies to Merge to Expand Robotic SI Business in Japan and ASEAN Countries January 30, 2023
  • President Joko Widodo Launches Indonesia’s 2023 ASEAN Chairmanship January 30, 2023
  • Toyota Tsusho, IIJ, NEC, and NTT Com Sign Contract with Uzbektelecom for Telecommunications Infrastructure Development Project January 27, 2023
  • Eisai: Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by European Medicines Agency January 27, 2023
  • SCIB Enforces Rights to Withdraw from Project January 27, 2023
  • TMC Announces Changes to Executive Structure January 27, 2023
  • Eccentric Engine launches Virtual Retail Cloud at NADA 2023 January 27, 2023
  • Nippon Steel, Mitsubishi Corporation and ExxonMobil to Evaluate and Establish CCS Value Chains in the Asia Pacific Region January 26, 2023
  • Kurita Water Industries and Hitachi Launch a Co-creation to Implement Solution in Society and Build an Ecosystem for a Sustainable Society with “Zero Environmental Impact” January 26, 2023
  • Four Companies Announce Joint Feasibility Study of Large-Scale and Wide-Area Carbon Capture and Storage (CCS) Value Chain Project Using Ship Transportation January 26, 2023
  • Mitsubishi Power Receives Order for H-25 Gas Turbine for Taiwan’s Chang Chun Petrochemical January 26, 2023
  • Palladium One Initiates 2023 Exploration Program and Expands the Tyko Nickel – Copper Project, Canada January 26, 2023
  • As Mentor by eDriving Passes 3.5 Billion Miles Driven, Analysis Confirms Program’s Ability to Reduce Risky Driving Behaviors January 26, 2023

Menu

  • Home
  • About Us
  • Contact Us
  • Term of Use
  • RSS

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
Copyright © 2023 Southeast Asia Chronicle All Rights Reserved By Seachronicle.Com